4.2 Article

The Potential Pathogenicity of Myelin Oligodendrocyte Glycoprotein Antibodies in the Optic Pathway

Related references

Note: Only part of the references are listed.
Article Neurosciences

Dose-dependent effect of myelin oligodendrocyte glycoprotein on visual function and optic nerve damage in experimental autoimmune encephalomyelitis

Valerio Castoldi et al.

Summary: In this study, female Dark Agouti rats were immunized with increasing doses of myelin oligodendrocyte glycoprotein (MOG) to develop experimental autoimmune encephalomyelitis (EAE), a preclinical model of multiple sclerosis. The results showed that increasing MOG dosage augmented visual function impairment in EAE, which could be monitored with noninvasive visual evoked potentials (VEPs) to assess demyelination and axonal loss along optic nerves (ONs).

JOURNAL OF NEUROSCIENCE RESEARCH (2022)

Article Clinical Neurology

OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and Multiple Sclerosis RNFL thickening in acute optic neuritis from MOGAD vs MS

John J. Chen et al.

Summary: This study demonstrates the potential of optical coherence tomography (OCT) in distinguishing acute optic neuritis (ON) in myelin oligodendrocyte glycoprotein antibody associated disorder (MOGAD) from multiple sclerosis (MS). The study found that pRNFL thickness measured by OCT can serve as a sensitive biomarker for confirming acute ON in MOGAD and can help differentiate MOGAD from MS. It also suggests that pRNFL thickening can aid in early diagnosis and guide disease-specific therapy in the acute setting.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2022)

Article Immunology

Progressive Retinal and Optic Nerve Damage in a Mouse Model of Spontaneous Opticospinal Encephalomyelitis

Laura Petrikowski et al.

Summary: In this study, inflammation and degeneration of the visual system were investigated in a spontaneous encephalomyelitis animal model. The findings showed concurrent inflammatory and degenerative mechanisms in the retina and optic nerve, involving the complement system.

FRONTIERS IN IMMUNOLOGY (2022)

Article Clinical Neurology

Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G in the CSF: Clinical Implication of Testing and Association With Disability

Young Nam Kwon et al.

Summary: The presence of CSF MOG-IgG improves the diagnosis of MOGAD in the absence of an MS phenotype, and intrathecal synthesis of MOG-IgG is associated with increased disability.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2022)

Article Clinical Neurology

Optic chiasm involvement in AQP-4 antibody-positive NMO and MOG antibody-associated disorder

Deena Tajfirouz et al.

Summary: This study compared the frequency and pattern of optic chiasm involvement in AQP4-IgG-ON and MOG-IgG-ON patients, finding that there was not a significant difference between the two. In cases with chiasmal involvement, MOG-IgG-ON was more likely to have longitudinally extensive optic nerve lesions compared to AQP4-IgG-ON.

MULTIPLE SCLEROSIS JOURNAL (2022)

Article Immunology

Retinal pathology in spontaneous opticospinal experimental autoimmune encephalitis mice

Jing Jin et al.

Summary: This study reveals that retinal ganglion cells are lost in a mouse model of myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD) following optic nerve inflammation. The retinal pathology observed in this model mirrors that seen in human optic neuritis, making it a valuable tool for studying neuroprotective compounds for MOGAD and other optic neuritis diseases.

JOURNAL OF NEUROIMMUNOLOGY (2022)

Review Immunology

Safety and efficacy of rituximab for relapse prevention in myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG)-associated disorders (MOGAD): A systematic review and meta-analysis

Gaurav Nepal et al.

Summary: This study aims to systematically evaluate the efficacy of rituximab in preventing relapses among patients with MOGAD. The meta-analysis of 13 studies found that rituximab effectively prevents relapses in MOGAD patients.

JOURNAL OF NEUROIMMUNOLOGY (2022)

Article Clinical Neurology

Longitudinal Retinal Changes in MOGAD

Frederike Cosima Oertel et al.

Summary: The study suggests that there is no attack-independent retinal damage in patients with MOGAD. However, ongoing neuroaxonal damage or edema resolution can occur for up to 12 months after ON, which is longer than what has been reported with other ON forms.

ANNALS OF NEUROLOGY (2022)

Review Immunology

B cells in central nervous system disease: diversity, locations and pathophysiology

Rajiv W. Jain et al.

Summary: Although B cells constitute a minor cell population in the central nervous system (CNS), they can contribute to CNS pathology, especially in multiple sclerosis, through secretion of antibodies and effector molecules and presentation of antigens. Jain and Yong discuss the roles of B cells in the CNS and the potential for targeting these cells in various neurological conditions.

NATURE REVIEWS IMMUNOLOGY (2022)

Letter Clinical Neurology

MOG expressing teratoma followed by MOG-IgG-positive optic neuritis

Brigitte Wildemann et al.

ACTA NEUROPATHOLOGICA (2021)

Review Ophthalmology

Ophthalmic manifestations of myelin oligodendrocyte glycoprotein-IgG-associated disorder other than optic neuritis: a systematic review

Amir R. Vosoughi et al.

Summary: MOGAD has been associated with various afferent and efferent ophthalmic manifestations apart from isolated optic neuritis. Awareness of these findings may result in earlier diagnosis and treatment.

BRITISH JOURNAL OF OPHTHALMOLOGY (2021)

Article Clinical Neurology

Complement Activation Is a Prominent Feature of MOGAD

Christian W. Keller et al.

Summary: MOG-antibody associated diseases account for a significant portion of patients with acquired demyelinating disorders, with elevated systemic complement activation observed in both adult and pediatric cases across all clinical syndromes. Complement inhibition should be considered for therapeutic merit in patients with MOGAD.

ANNALS OF NEUROLOGY (2021)

Article Neurosciences

Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms

Xiaowen Huang et al.

Summary: The blood-brain barrier is a crucial physiological barrier that separates the central nervous system from the peripheral circulation. Disruption of the BBB by peripheral inflammation can lead to various CNS diseases.

CNS NEUROSCIENCE & THERAPEUTICS (2021)

Article Clinical Neurology

Myelitis in inflammatory disorders associated with myelin oligodendrocyte glycoprotein antibody and aquaporin-4 antibody: A comparative study in Chinese Han patients

Jingzi ZhangBao et al.

Summary: Myelitis is less common in MOGAD and has distinct features compared to AQP4-ab-positive NMOSD, such as age, symptoms during the disease course, and imaging findings.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Article Multidisciplinary Sciences

A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis

Christina Krienke et al.

Summary: The study demonstrates the potential use of modified m1 Psi mRNA in the treatment of multiple sclerosis, showing its ability to suppress the disease, promote the development of T-reg cell populations, and enhance bystander immunosuppression.

SCIENCE (2021)

Article Clinical Neurology

Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel

Livnat Brill et al.

Summary: MOGAD are distinct autoimmune diseases that occur at all stages of life with a significantly higher prevalence in children; the main clinical presenting phenotype in the entire cohort is ON and young children most often presented with ON or ADEM.

FRONTIERS IN NEUROLOGY (2021)

Article Clinical Neurology

Features of MOG required for recognition by patients with MOG antibody-associated disorders

Caterina Macrini et al.

Summary: The study aimed to understand the essential structural features of MOG for recognition by autoantibodies in patients. The results showed that patients with MOG antibodies recognize full-length MOG better than its N-terminal part and require bivalent binding. This suggests that the pathogenicity of MOG antibodies may be mediated by mechanisms other than complement activation.

BRAIN (2021)

Article Clinical Neurology

Exposure to TNF inhibitors is rare at MOGAD presentation

Vyanka Redenbaugh et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2021)

Review Clinical Neurology

Interleukin-6 inhibition with tocilizumab for relapsing MOG-IgG associated disorder (MOGAD): A case-series and review

Paul M. Elsbernd et al.

Summary: The study summarized the experience with tocilizumab, an IL-6 inhibitor, for highly-relapsing MOGAD and analyzed the immunopathologic rationale. The results suggest that tocilizumab may be a promising therapeutic option for reducing relapse rate and dependence on oral prednisone in patients with MOGAD. Further research is needed to establish the safety and efficacy of IL-6 inhibition in MOGAD.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)

Article Clinical Neurology

Five-year visual outcomes after optic neuritis in anti-MOG antibody-associated disease

Tetsuya Akaishi et al.

Summary: This study evaluated the long-term visual outcomes after optic neuritis in patients with MOGAD, MS, and anti-AQP4-positive NMOSD. It found that patients with MOGAD had better visual recovery compared to MS and significantly better than patients with anti-AQP4-positive NMOSD.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)

Article Immunology

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and Varicella Zoster Virus Infection-Frequency of an Association

Franziska Di Pauli et al.

Summary: The study did not find MOG-IgG associated with VZV infections, but identified cases with AQP4 IgG related disorders.

FRONTIERS IN IMMUNOLOGY (2021)

Article Clinical Neurology

No strong HLA association with MOG antibody disease in the UK population

Melissa Grant-Peters et al.

Summary: Improvements in assays for detecting MOG antibodies have led to the recognition of MOG-antibody-associated disease as a novel disorder. However, the etiology of MOGAD remains largely unknown. HLA analysis in MOGAD patients of European ancestry did not reveal any HLA class II associations, raising questions about the mechanism of anti-MOG antibody generation. A weak protective association of HLA-C*03:04 was observed, highlighting the need for continued efforts to better understand MOGAD genetics and pathophysiology.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)

Review Immunology

Clinical and neuroimaging findings in MOGAD-MRI and OCT

Frederik Bartels et al.

Summary: MOGAD is a rare autoimmune neuroinflammatory disorder different from classic multiple sclerosis, with distinguishing features seen through magnetic resonance imaging and optical coherence tomography.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2021)

Article Clinical Neurology

Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders

Elia Sechi et al.

Summary: MOGAD patients more frequently experience complete resolution of MRI T2 lesions compared to AQP4-IgG-NMOSD and MS. This finding has implications for diagnosis, disease activity monitoring, and clinical trial design, while also providing insights into the pathogenesis of CNS demyelinating diseases.

NEUROLOGY (2021)

Article Immunology

Targeted Expression of Myelin Autoantigen in the Periphery Induces Antigen-Specific T and B Cell Tolerance and Ameliorates Autoimmune Disease

Shin-Young Na et al.

Summary: The study demonstrates that ectopic expression of MOG in immune organs can induce MOG-specific tolerance and long-lasting protection, potentially serving as a therapeutic strategy for specific autoantigen-driven autoimmune diseases.

FRONTIERS IN IMMUNOLOGY (2021)

Article Clinical Neurology

Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases

Kathrin Schanda et al.

Summary: The study analyzed different isoforms of MOG and their binding patterns in patients with non-MS demyelinating diseases, identifying three distinct binding patterns. These patterns were found to be associated with non-MS demyelinating diseases and had unique immunologic characteristics without differences in clinical phenotypes or disease course. This novel finding could potentially improve MOG-IgG assays and enhance understanding of the pathophysiologic role of MOG-IgG.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)

Article Clinical Neurology

Alterations in the Retinal Vascular Network and Structure in MOG Antibody-Associated Disease: An Optical Coherence Tomography Angiography Study

Jian Yu et al.

Summary: MOG-Ab-associated optic neuritis is linked to significant decreases in retinal structure and vessel density, without notable impairments in visual function. Furthermore, peripapillary vessel density may serve as a predictor for visual outcomes in patients with MOG-Ab-associated optic neuritis.

JOURNAL OF NEURO-OPHTHALMOLOGY (2021)

Review Immunology

Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease

Joseph A. Lopez et al.

Summary: Autoimmunity plays a significant role in the pathogenesis of demyelination, affecting diseases like multiple sclerosis, neuromyelitis optica spectrum disorders, and myelin oligodendrocyte glycoprotein antibody-associated disease. While these diseases share similarities, differences in clinical presentations and lesion pathologies aid in differential diagnoses and understanding of disease pathogenesis.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2021)

Review Clinical Neurology

Targeting B cells to modify MS, NMOSD, and MOGAD Part 2

Jonas Graf et al.

Summary: This article discusses various immunotherapies targeting B cell-related proteins, which have shown efficacy in diseases like multiple sclerosis and neuromyelitis optica spectrum disorder. It focuses on monoclonal antibody B cell-depleting strategies in NMOSD and related research on MOG immunoglobulin G-associated disease, as well as the safety profile of long-term B-cell depletion. Additionally, it examines the implications of the current COVID-19 pandemic on the management of patients with these disorders and the use of B cell-depleting agents.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)

Article Clinical Neurology

Early predictors of epilepsy and subsequent relapse in children with acute disseminated encephalomyelitis

Thomas Rossor et al.

MULTIPLE SCLEROSIS JOURNAL (2020)

Article Ophthalmology

MOG-Ab prevalence in optic neuritis and clinical predictive factors for diagnosis

Jean-Baptiste Ducloyer et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2020)

Review Immunology

Meningeal Immunity and Its Function in Maintenance of the Central Nervous System in Health and Disease

Kalil Alves de Lima et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)

Article Clinical Neurology

Myelin oligodendrocyte glycoprotein-associated disorders are associated with HLA subtypes in a Chinese paediatric-onset cohort

Xiaobo Sun et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)

Article Clinical Neurology

HLA association in MOG-IgG- and AQP4-IgG-related disorders of the CNS in the Dutch population

Arlette L. Bruijstens et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)

Article Clinical Neurology

Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder

John J. Chen et al.

NEUROLOGY (2020)

Letter Clinical Neurology

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis and Myelitis in COVID-19

Siwei Zhou et al.

JOURNAL OF NEURO-OPHTHALMOLOGY (2020)

Article Clinical Neurology

Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients

Daniel H. Whittam et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)

Review Clinical Neurology

Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology

Kazuo Fujihara et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)

Review Clinical Neurology

Assessing the anterior visual pathway in optic neuritis: recent experimental and clinical aspects

Michael Dietrich et al.

CURRENT OPINION IN NEUROLOGY (2019)

Article Multidisciplinary Sciences

Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation

Marta Joana Costa Jordao et al.

SCIENCE (2019)

Letter Clinical Neurology

Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders

Sara Mariotto et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)

Article Immunology

Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease

Alvaro Cobo-Calvo et al.

JOURNAL OF NEUROINFLAMMATION (2019)

Review Clinical Neurology

When encephalitogenic T cells collaborate with microglia in multiple sclerosis

Yifei Dong et al.

NATURE REVIEWS NEUROLOGY (2019)

Article Neurosciences

Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination

Fiona Tea et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)

Review Neurosciences

The CNS Immune Landscape from the Viewpoint of a T Cell

Sarah Mundt et al.

TRENDS IN NEUROSCIENCES (2019)

Article Clinical Neurology

Identification of circulating MOG-specific B cells in patients with MOG antibodies

Stephan Winklmeier et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)

Article Ophthalmology

Antibodies to myelin oligodendrocyte glycoprotein in chronic relapsing inflammatory optic neuropathy

Hongjuan Liu et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2019)

Review Immunology

Immune cells and CNS physiology: Microglia and beyond

Geoffrey T. Norris et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2019)

Article Clinical Neurology

The prevalence and prognostic value of myelin oligodendrocyte glycoprotein antibody in adult optic neuritis

Hongjuan Liu et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)

Review Clinical Neurology

Myelin oligodendrocyte glycoprotein antibodies in neurological disease

Markus Reindl et al.

NATURE REVIEWS NEUROLOGY (2019)

Article Clinical Neurology

Brain histopathological study and prognosis in MOG antibody-associated demyelinating pseudotumor

Yaqing Shu et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)

Article Clinical Neurology

Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein

Melania Spadaro et al.

ANNALS OF NEUROLOGY (2018)

Review Clinical Neurology

Mechanisms for lesion localization in neuromyelitis optica spectrum disorders

Monika Bradl et al.

CURRENT OPINION IN NEUROLOGY (2018)

Article Immunology

Neuroinflammation: Microglia and T cells Get Ready to Tango

Sjoerd T. T. Schetters et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Biochemistry & Molecular Biology

Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis

Ivan Jelcic et al.

Article Clinical Neurology

Etiologies of acute demyelinating optic neuritis: an observational study of 110 patients

R. Deschamps et al.

EUROPEAN JOURNAL OF NEUROLOGY (2017)

Review Medicine, Research & Experimental

Understanding the functions and relationships of the glymphatic system and meningeal lymphatics

Antoine Louveau et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Article Clinical Neurology

A population-based prospective study of optic neuritis

K. Soelberg et al.

MULTIPLE SCLEROSIS JOURNAL (2017)

Article Multidisciplinary Sciences

Visualizing context-dependent calcium signaling in encephalitogenic T cells in vivo by two-photon microscopy

Nikolaos I. Kyratsous et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Clinical Neurology

A population-based prospective study of optic neuritis

K. Soelberg et al.

MULTIPLE SCLEROSIS JOURNAL (2017)

Article Clinical Neurology

A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection

Masataka Nakamura et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)

Article Clinical Neurology

Clinical presentation and prognosis in MOG-antibody disease: a UK study

Maciej Jurynczyk et al.

BRAIN (2017)

Editorial Material Clinical Neurology

ADEM-LIKE PRESENTATION, ANTI-MOG ANTIBODIES, AND MS PATHOLOGY: TWO CASE REPORTS

Peter Koervelyessy et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)

Review Immunology

T cell responses in the central nervous system

Thomas Korn et al.

NATURE REVIEWS IMMUNOLOGY (2017)

Article Neurosciences

Oligodendrocyte death results in immune-mediated CNS demyelination

Maria Traka et al.

NATURE NEUROSCIENCE (2016)

Editorial Material Clinical Neurology

Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies

Kimihiko Kaneko et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)

Article Immunology

Origin, fate and dynamics of macrophages at central nervous system interfaces

Tobias Goldmann et al.

NATURE IMMUNOLOGY (2016)

Article Multidisciplinary Sciences

Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease

Anne-Christine Flach et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Cell Biology

The myelin oligodendrocyte glycoprotein directly binds nerve growth factor to modulate central axon circuitry

H. -Christian von Buedingen et al.

JOURNAL OF CELL BIOLOGY (2015)

Article Immunology

A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules

Aleksanteri Aspelund et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2015)

Review Immunology

Revisiting the Mechanisms of CNS Immune Privilege

Antoine Louyeau et al.

TRENDS IN IMMUNOLOGY (2015)

Article Multidisciplinary Sciences

Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction

Sherin J. Rouhani et al.

NATURE COMMUNICATIONS (2015)

Article Clinical Neurology

Histopathology and clinical course of MOG-antibody-associated encephalomyelitis

Melania Spadaro et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)

Article Neurosciences

Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain

Samira Saadoun et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)

Article Clinical Neurology

Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton

Russell C. Dale et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2014)

Review Immunology

Capture, crawl, cross: the T cell code to breach the blood-brain barriers

Britta Engelhardt et al.

TRENDS IN IMMUNOLOGY (2012)

Article Ophthalmology

Visual Functional and Histopathological Correlation in Experimental Autoimmune Optic Neuritis

Yoshimichi Matsunaga et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)

Review Immunology

Lymph node stroma broaden the peripheral tolerance paradigm

Anne L. Fletcher et al.

TRENDS IN IMMUNOLOGY (2011)

Article Immunology

EAE: An immunologist's magic eye

Gurumoorthy Krishnamoorthy et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2009)

Article Biochemistry & Molecular Biology

Alternative isoforms of myelin/oligodendrocyte glycoprotein with variable cytoplasmic domains are expressed in human brain

Chantal Allamargot et al.

JOURNAL OF NEUROCHEMISTRY (2007)

Article Biochemistry & Molecular Biology

Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein

Kevin C. O'Connor et al.

NATURE MEDICINE (2007)

Article Biochemistry & Molecular Biology

Complex alternative splicing of the myelin oligodendrocyte glycoprotein gene is unique to human and non-human primates

Cecile Delarasse et al.

JOURNAL OF NEUROCHEMISTRY (2006)

Article Medicine, Research & Experimental

Myelin oligodendrocyte glycoprote in-specific T and B cells cooperate to induce a Devic-like disease in mice

Estelle Bettelli et al.

JOURNAL OF CLINICAL INVESTIGATION (2006)

Article Medicine, Research & Experimental

Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell B cell cooperation

Gurumoorthy Krishnamoorthy et al.

JOURNAL OF CLINICAL INVESTIGATION (2006)

Article Biochemistry & Molecular Biology

Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis

M Greter et al.

NATURE MEDICINE (2005)

Article Multidisciplinary Sciences

The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis

CS Clements et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Immunology

B cells regulate autoimmunity by provision of IL-10

S Fillatreau et al.

NATURE IMMUNOLOGY (2002)